))
Episode 17: Among the topics: Takotsubo Syndrome - Arrhythmogenic Right Ventricular Cardiomyopathy
Manage episode 407315182 series 3559418
Content provided by European Society of Cardiology. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by European Society of Cardiology or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
ESC TV Today brings you concise analysis from the world's leading experts, so you can stay on top of what's happening in your field quickly.
This episode covers:
Cardiology This Week: A concise summary of recent studies
Takotsubo Syndrome
Arrhythmogenic Right Ventricular Cardiomyopathy
Mythbusters – Red rice - an alternative to statins?
Host: Rick Grobbee
Guests: Kristina Haugaa and Thomas Luescher
Want to watch that episode? Go to: https://esc365.escardio.org/event/1077
Disclaimer
This programme is supported by Siemens Healthineers in the form of an educational grant. The scientific content and opinions expressed in the programme have not been influenced in any way by its sponsor.
This programme is intended for health care professionals only and is to be used for educational purposes.
The European Society of Cardiology (ESC) does not aim to promote medicinal products nor devices.
Any views or opinions expressed are the presenters' own and do not reflect the views of the ESC.
Declarations of interests
Stephan Achenbach, Rick Grobbee, Kristina Haugaa, Nicolle Kraenkel and Thomas Luescher have declared to have no potential conflicts of interest to report.
Carlos Aguiar has declared to have potential conflicts of interest to report: personal fees for consultancy and/or speaker fees from Abbott, Alnylam, Amgen, AstraZeneca, Bayer, Boehringer-Ingelheim, Daiichi-Sankyo, Ferrer, Gilead, Lilly, Novartis, Pfizer, Sanofi, Servier, Tecnimede.
Davide Capodanno has declared to have potential conflicts of interest to report: Sanofi, Daiichi Sankyo, Terumo, Medtronic, Chiesi.
Emma Svennberg has declared to have potential conflicts of interest to report: institutional research grants from Bayer, Bristol-Myers, Squibb-Pfizer, Boehringer- Ingelheim, Johnson & Johnson, Merck Sharp & Dohme.
39 episodes
Share
